Direct-To-Consumer Genetic Testing Market Expected Huge CAGR of +11% with Top Vendors like: Laboratory Corporation of America, Myriad Genetics, Inc., Quest Diagnostics, Counsyl, Inc., Gene by Gene

By | June 13, 2019

Analysts forecast the Global Direct-To-Consumer Genetic Testing Market to grow at a CAGR of +11% during the period 2017-2023.

The Global Direct-To-Consumer Genetic Testing Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Direct-To-Consumer Genetic Testing industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data.

Direct-to-consumer genetic testing provides people access to their genetic information without necessarily involving a healthcare provider or health insurance company in the process.

Get Sample Copy Of this Report@           

https://www.reportconsultant.com/request_sample.php?id=1029

Top Key Players:

23andMe, Inc., Laboratory Corporation of America, Myriad Genetics, Inc., Quest Diagnostics, Counsyl, Inc., Gene by Gene, and Positive Bioscience Ltd. In order to gain competitive advantage in the market, these market players are actively involved in various growth strategies such as collaborations, partnerships, agreements, and new product launches.

Other Prominent Vendors in the market are: African Ancestry, Alpha Biolaboratories, Ambry Genetics, AncestrybyDNA, Anglia DNA Services, Canadian DNA Services, Centrillion Technology, Color Genomics, Counsyl, Dante Labs, DNA Diagnostics Center, DNA Family Check, DNA4Life, DNA Services of America and More.

Geographically, the Global Direct-To-Consumer Genetic Testing Market like are broadly divided into:

Americas

APAC

EMEA

Ask For Discount@

https://www.reportconsultant.com/ask_for_discount.php?id=1029

Direct-To-Consumer Genetic Testing Market according to this report, one of the major drivers for this market is Chronic disorders in adult population. People between the ages of 18 to 49 are susceptible to chronic diseases such as cardiovascular diseases (CVDs) and type 2 diabetes. A study conducted by the CDC in 2016 found that in 2012, around 117 million adults were suffering from one or more chronic diseases such as heart disease or cancer.

Global Direct-To-Consumer Genetic Testing Market study utilizes a SWOT analysis, this report covers market landscape and its growth prospects over the coming years along with the product life cycle, comparing it to the relevant products from across industries that had already been commercialized details the potential for various applications, discussing about recent product innovations and gives an overview on potential regional market.